[Faster Diagnosis of Rare Diseases with Artificial Intelligence-A Precept of Ethics, Economy and Quality of Life]

Overview

Journal Inn Med (Heidelb)

Specialty General Medicine

Date 2023 Oct 20

PMID 37861723

Authors

Lukas Volkel

Annette D Wagner

Affiliations

Soon will be listed here.

Abstract

Background: Approximately 300 million people worldwide suffer from a rare disease. An optimal treatment requires a successful diagnosis. This takes a particularly long time, especially for rare diseases. Digital diagnosis support systems could be important aids in accelerating a successful diagnosis in the future.

Objective: The current possibilities of digital diagnostic support systems in the diagnosis of rare diseases and questions that still need to be clarified are presented in relation to the parameters of ethics, economy and quality of life.

Material And Methods: Current research results of the authors were compiled and discussed in the context of the current literature. A case study is used to illustrate the potential of digital diagnostic support systems.

Results: Digital diagnostic support systems and experts together can accelerate the successful diagnosis in patients with rare diseases. This could have a positive impact on patients' quality of life and lead to potential savings in direct and indirect costs in the healthcare system.

Conclusion: Ensuring data security, legal certainty and functionality in the use of digital diagnostic support systems is of great importance in order to create trust among experts and patients. Continuous further development of the systems by means of artificial intelligence (AI) could also enable patients to accelerate diagnosis in the future.

References

Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R . Diagnosis support systems for rare diseases: a scoping review. Orphanet J Rare Dis. 2020; 15(1):94. PMC: 7164220. DOI: 10.1186/s13023-020-01374-z. View

Li X, Wang Y, Wang D, Yuan W, Peng D, Mei Q . Improving rare disease classification using imperfect knowledge graph. BMC Med Inform Decis Mak. 2019; 19(Suppl 5):238. PMC: 6894101. DOI: 10.1186/s12911-019-0938-1. View

Rother A, Schwerk N, Brinkmann F, Klawonn F, Lechner W, Grigull L . Diagnostic Support for Selected Paediatric Pulmonary Diseases Using Answer-Pattern Recognition in Questionnaires Based on Combined Data Mining Applications--A Monocentric Observational Pilot Study. PLoS One. 2015; 10(8):e0135180. PMC: 4534438. DOI: 10.1371/journal.pone.0135180. View

Mueller T, Jerrentrup A, Bauer M, Fritsch H, Schaefer J . Characteristics of patients contacting a center for undiagnosed and rare diseases. Orphanet J Rare Dis. 2016; 11(1):81. PMC: 4915144. DOI: 10.1186/s13023-016-0467-2. View

Bloss S, Klemann C, Rother A, Mehmecke S, Schumacher U, Mucke U . Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey. PLoS One. 2017; 12(2):e0172532. PMC: 5325301. DOI: 10.1371/journal.pone.0172532. View

Hallowell N, Badger S, Sauerbrei A, Nellaker C, Kerasidou A . "I don't think people are ready to trust these algorithms at face value": trust and the use of machine learning algorithms in the diagnosis of rare disease. BMC Med Ethics. 2022; 23(1):112. PMC: 9670402. DOI: 10.1186/s12910-022-00842-4. View

Hirsch M, Ronicke S, Krusche M, Wagner A . Rare diseases 2030: how augmented AI will support diagnosis and treatment of rare diseases in the future. Ann Rheum Dis. 2020; 79(6):740-743. PMC: 7286047. DOI: 10.1136/annrheumdis-2020-217125. View

Pushpakom S, Iorio F, Eyers P, Jane Escott K, Hopper S, Wells A . Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018; 18(1):41-58. DOI: 10.1038/nrd.2018.168. View

Shen F, Liu S, Wang Y, Wang L, Afzal N, Liu H . Leveraging Collaborative Filtering to Accelerate Rare Disease Diagnosis. AMIA Annu Symp Proc. 2018; 2017:1554-1563. PMC: 5977716. View

10.

Mazzucato M, Visona Dalla Pozza L, Manea S, Minichiello C, Facchin P . A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry. Orphanet J Rare Dis. 2014; 9:37. PMC: 4000007. DOI: 10.1186/1750-1172-9-37. View

11.

Lopez-Bastida J, Oliva-Moreno J, Linertova R, Serrano-Aguilar P . Social/economic costs and health-related quality of life in patients with rare diseases in Europe. Eur J Health Econ. 2016; 17 Suppl 1:1-5. DOI: 10.1007/s10198-016-0780-7. View

12.

Gambhir S, Malik S, Kumar Y . Role of Soft Computing Approaches in HealthCare Domain: A Mini Review. J Med Syst. 2016; 40(12):287. DOI: 10.1007/s10916-016-0651-x. View

13.

Willmen T, Volkel L, Ronicke S, Hirsch M, Kaufeld J, Rychlik R . Health economic benefits through the use of diagnostic support systems and expert knowledge. BMC Health Serv Res. 2021; 21(1):947. PMC: 8431907. DOI: 10.1186/s12913-021-06926-y. View

14.

Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I . Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019; 14(1):99. PMC: 6500578. DOI: 10.1186/s13023-019-1075-8. View

15.

Winter P, Carusi A . (De)troubling transparency: artificial intelligence (AI) for clinical applications. Med Humanit. 2022; 49(1):17-26. PMC: 9985768. DOI: 10.1136/medhum-2021-012318. View

16.

Ronicke S, Hirsch M, Turk E, Larionov K, Tientcheu D, Wagner A . Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study. Orphanet J Rare Dis. 2019; 14(1):69. PMC: 6427854. DOI: 10.1186/s13023-019-1040-6. View

17.

Jia J, Wang R, An Z, Guo Y, Ni X, Shi T . RDAD: A Machine Learning System to Support Phenotype-Based Rare Disease Diagnosis. Front Genet. 2018; 9:587. PMC: 6288202. DOI: 10.3389/fgene.2018.00587. View

18.

Ferreira C . The burden of rare diseases. Am J Med Genet A. 2019; 179(6):885-892. DOI: 10.1002/ajmg.a.61124. View